| Product Code: ETC9961860 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Cardiovascular Diagnostics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Cardiovascular Diagnostics Market - Industry Life Cycle |
3.4 United States (US) Cardiovascular Diagnostics Market - Porter's Five Forces |
3.5 United States (US) Cardiovascular Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Cardiovascular Diagnostics Market Revenues & Volume Share, By Point-of-Care Testing, 2021 & 2031F |
3.7 United States (US) Cardiovascular Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Cardiovascular Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in the US |
4.2.2 Technological advancements in cardiovascular diagnostic tools |
4.2.3 Growing awareness about the importance of early detection and diagnosis of cardiovascular diseases |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for cardiovascular diagnostic products |
4.3.2 High cost associated with cardiovascular diagnostic tests and procedures |
4.3.3 Limited reimbursement options for certain cardiovascular diagnostic tests |
5 United States (US) Cardiovascular Diagnostics Market Trends |
6 United States (US) Cardiovascular Diagnostics Market, By Types |
6.1 United States (US) Cardiovascular Diagnostics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Electrocardiogram (ECG) system, 2021- 2031F |
6.1.4 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Resting ECG Systems, 2021- 2031F |
6.1.5 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Cardiopulmonary Stress Testing Systems, 2021- 2031F |
6.1.6 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Holter Monitoring Devices, 2021- 2031F |
6.1.7 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Event Monitoring Devices, 2021- 2031F |
6.1.8 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Implantable Loop Recorder (ILR), 2021- 2031F |
6.2 United States (US) Cardiovascular Diagnostics Market, By Point-of-Care Testing |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Analyzers, 2021- 2031F |
6.2.3 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Lipoprotein Test Kits, 2021- 2031F |
6.2.4 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Angiotensin Test Kits, 2021- 2031F |
6.2.5 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Fibrinogen Test Kits, 2021- 2031F |
6.2.6 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Serum Uric Acid Test Kits, 2021- 2031F |
6.2.7 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By High-Sensitivity CRP (hs-CRP) Kits, 2021- 2031F |
6.3 United States (US) Cardiovascular Diagnostics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Cardiac Catheterization Labs, 2021- 2031F |
6.3.6 United States (US) Cardiovascular Diagnostics Market Revenues & Volume, By Diagnostic Imaging Centers, 2021- 2031F |
7 United States (US) Cardiovascular Diagnostics Market Import-Export Trade Statistics |
7.1 United States (US) Cardiovascular Diagnostics Market Export to Major Countries |
7.2 United States (US) Cardiovascular Diagnostics Market Imports from Major Countries |
8 United States (US) Cardiovascular Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of new cardiovascular diagnostic technologies in the US |
8.2 Average turnaround time for cardiovascular diagnostic test results |
8.3 Number of partnerships and collaborations between healthcare providers and diagnostic companies for cardiovascular diagnostics |
8.4 Rate of utilization of preventive cardiovascular diagnostic services in the US |
9 United States (US) Cardiovascular Diagnostics Market - Opportunity Assessment |
9.1 United States (US) Cardiovascular Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Cardiovascular Diagnostics Market Opportunity Assessment, By Point-of-Care Testing, 2021 & 2031F |
9.3 United States (US) Cardiovascular Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Cardiovascular Diagnostics Market - Competitive Landscape |
10.1 United States (US) Cardiovascular Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Cardiovascular Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here